● Recruiting

CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection

Condition: HCC · Sponsor: CARsgen Therapeutics Co., Ltd.

PhasePhase 1

Planned participants30

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

A Single-arm, Open-label, Multicenter, Phase Ib Clinical Trial to Evaluate the Safety and Efficacy of CT011 Autologous CAR-T Cells in Patients with Hepatocellular Carcinoma at Risk of Recurrence after Surgical Resection.

This description comes directly from the study's public registry record.

Talk to the study team

Lifeng Zhang · 86-21-54489928 · lifengzhang@carsgen.com

Tianci Su · 86-21-64501828 · tiancisu@carsgen.com

Always discuss trial participation with your own doctor first.

Locations (15)

Cancer Hospital Chinese Academy of Medical Sciences	Beijing, China	Recruiting
Hunan Provincial People's Hospital	Changsha, China	Recruiting
Sichuan Cancer Hospital	Chengdu, China	Recruiting
West China Hospital of Sichuan University	Chengdu, China	Recruiting
Chongqing university ca cer hospital	Chongqing, China	Recruiting
Mengchao hepatobiliary hospital of fujian medical university	Fuzhou, China	Recruiting
Sun Yat-sen University Cancer Center	Guanzhou, China	Recruiting
Sir Run Run Shaw Hospital Zhejiang University School of Medicine	Hangzhou, China	Recruiting
The second affiliated hospital zhejiang university school of medicine	Hangzhou, China	Recruiting
Zhongshan Hospital Fudan University	Shanghai, China	Recruiting
Liaoning Cancer Hospital	Shenyang, China	Recruiting
The first hospital of china medical university	Shenyang, China	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06560827